Spinal Tech

Carlsbad, Calif.-based SeaSpine is commercially launching its Vu a•POD Prime NanoMetalene System.

Zimmer Biomet Holdings has announced its fourth quarter and full year financial results for 2016.

President Donald Trump met with pharmaceutical executives earlier this week, according to U.S. News and World Report.

Last year there were fewer FDA approvals and it took longer for medical devices to achieve approved status; however with President Donald Trump's vows to eliminate wasteful regulations that could change in 2017, according to Seeking Alpha.

Gateway Investment Advisers, owner of $2,560,000-worth Stryker shares, has cut back its stake in shares in the company.

Transparency Market Research reports that the development of robotic spine surgery systems has combined with other factors to improve the market's prospects heading into the future.

The global neurology endoscopy devices market is set to grow at a compound annual growth rate of more than 7 percent between 2017 and 2021, a Technavio report found.

SpinalCyte, a tissue engineering technology company based in Houston, has announced the enrollment of the first patient to partake in a study for the development of CybroCell.

The traditional fusion material — collecting bone graft from the iliac crest — lost traction when BMP became available. Now, fewer surgeons are trained in iliac crest bone harvesting, says Dr. Bae, but BMP isn't always the best option for…

In a recent press release, SpineGuard (FR0011464452 – ALSGD), an innovative company that develops and markets disposable medical devices to make spine surgery safer, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new…